version française

Strategic Partnership to Produce High-Quality Cannabis Softgels

ATHOLVILLE , New Brunswick , July 16, 2018 – Zenabis Ltd. (“Zenabis” or “the Company” and Capcium Inc. (“Capcium”) announced today that the companies have signed a long-term strategic manufacturing agreement to produce high quality cannabis-based softgel capsules.

“Signing a manufacturing agreement with Capcium ensures that our patients will have access to a reliable and high-quality supply of cannabis-based softgels,” said John Kondrosky , COO of Zenabis. “We are excited to move forward with this partnership, as it directly supports Zenabis’ overall growth strategy and positions us a leading competitor in this growing category of easier to use cannabis products.”

Capcium, a privately-owned Montreal-based global leader in the encapsulation of oils, has emerged as one of the leading value-added manufacturers of cannabis softgels. Production of high precision dose softgels is a difficult process, but through its extensive pharmaceutical and encapsulation experience , Capcium has developed expertise that can be applied to the cannabis industry. Capcium now has the resources to produce very high-quality production at low costs.

Sylvain Duvernay, CEO of Capcium, added, “Zenabis is one of the largest Canadian Licensed Producer’s and will be a key supplier of cannabis products to the Canadian market. Teaming up with this impressive, professional and driven LP , will allow Capcium to continue to supply high quality products to Zenabis’ extensive customer base.”

Upon the completion of Capcium’s new state-of-the-art cGMP facility, scheduled for Q4 2019 (the “cGMP facility”), Zenabis will transfer all its softgel manufacturing volume to the new Capcium facility under a long-term manufacturing agreement. Capcium will be the exclusive manufacturer of Zenabis’ global cannabis softgel products during the initial term of the manufacturing agreement.

About Zenabis Ltd.

Zenabis Ltd. is a privately-held, cannabis company with one of the largest, federally licensed indoor medical cultivation footprints in Canada. Zenabis currently operates two licensed production facilities in British Columbia and New Brunswick, with a third coming shortly in Nova Scotia. These facilities encompass 660,000 square feet of indoor pharmaceutical grade cannabis production space across Canada. Zenabis operations are strategically positioned on Canada’s coasts, facilitating national distribution and access to international markets. Zenabis is currently working towards globally recognized EU GMP certifications.

Zenabis has one of the most experienced management teams in the industry, with an extensive background in retail consumer packaged goods, global pharmaceutical sales and manufacturing, quality assurance, and commercialized cultivation. Their growing team has more than two decades of experience in organic cultivation and distribution of herbs and nutraceutical products throughout the Americas, North Africa, and the Middle East. Their sales team has more than two decades in product development, commercialization, and retail and pharmaceutical sales including international distribution.

 

For more information , please contact Gurdeep Bains at media@zenabis.com

Join us on Facebook : https://www.facebook.com/zenabismmj/

Follow us on Twitter : @Zenabis

About Capcium Inc.

Capcium Inc. is a Montreal-based contract manufacturing platform specializing in softgel encapsulation. Capcium is transforming the cannabis industry by providing Licensed Producers with high-value, high-quality cannabis products. Capcium presently holds a nutraceutical license from Health Canada and will apply to be fully ACMPR licensed for cannabis transformation in its new state-of-the-art manufacturing facility in Pointe-Claire, Quebec.